Non-Small Cell Lung Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with advanced primary non-small cell lung cancer diagnosed by pathology or cytology; 2. In patients without dysfunction of main organs, blood routine, lung, liver, kidney and heart functions were basically normal; 3. Ros1 fusion was detected by fish, PCR or NGS; 4. Patients who agreed to receive oral targeted therapy with clotriminib; 5. Patients who understand the risk of treatment and sign informed consent voluntarily.
Exclusion criteria
Exclusion criteria: 1. Patients with disorder of thinking or consciousness, poor compliance and no complete behavior ability; 2. Patients with malignant tumor in cancer family or known family; 3. Patients who had previously suffered from other malignant tumors except lung cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Crizotinib resistance; | — |
Countries
China
Contacts
National Cancer Center / Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences